Natantis Overview

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $262K

  • Investors
  • 5

Natantis General Information

Description

Developer of a cell-free deoxyribonucleic acid metagenomic workflow intended to identify sepsis-causing pathogens. The company's technology identifies viruses, bacteria, fungi, and various parasites at the species level, directly from a venous blood sample, providing clinicians with a sequencing assay and delivering a clinically actionable result in the form of a list of top pathogens.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 32/5 Montpelier Park
  • Edinburgh EH10 4NJ
  • Scotland, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 32/5 Montpelier Park
  • Edinburgh EH10 4NJ
  • Scotland, United Kingdom

Natantis Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Natantis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 26-Dec-2024 $262K Completed Generating Revenue
5. Grant Completed Startup
4. Accelerator/Incubator 14-Nov-2023 Completed Startup
3. Accelerator/Incubator 01-Aug-2019 Completed Startup
2. Grant 03-Dec-2018 $739K Completed Startup
1. University Spin-Out Completed Startup
To view Natantis’s complete valuation and funding history, request access »

Natantis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
UK Research and Innovation Medical Research Council Venture Capital Minority
SantanderX Accelerator/Incubator
Merck Corporation Minority
Scottish Enterprise Growth/Expansion
Heriot-Watt University University Minority
To view Natantis’s complete investors history, request access »

Natantis FAQs

  • Where is Natantis headquartered?

    Natantis is headquartered in Edinburgh, United Kingdom.

  • What industry is Natantis in?

    Natantis’s primary industry is Biotechnology.

  • Is Natantis a private or public company?

    Natantis is a Private company.

  • What is Natantis’s current revenue?

    The current revenue for Natantis is .

  • How much funding has Natantis raised over time?

    Natantis has raised $262K.

  • Who are Natantis’s investors?

    UK Research and Innovation Medical Research Council, SantanderX, Merck, Scottish Enterprise, and Heriot-Watt University have invested in Natantis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process